Irlab Therapeutics AB (6IRA)
Market Open
12 Aug, 06:08
XFRA XFRA Primary €
0. 14
+0
+1.0417%
€
9.6M Market Cap
- P/E Ratio
- Div Yield
2,040 Volume
- Eps
€ 0.13
Previous Close Want to track 6IRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Irlab Therapeutics AB (6IRA) Statistics
Valuation metrics
Market Cap 9.6M
Enterprise value -42.31M
Trailing P/E (ttm) -0.07
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 0.17
Price/Book (mrq) 0.23
Enterprise Value/Revenue -0.74
Enterprise Value/EBITDA 0.5
Overview
Shares outstanding 84.94M
Float 56.07M
Shares short -
% Held by insiders 0.36%
% Held by institutions 0.17%
Average volume (10 days) 378
Average volume (90 days) 479
Price summary
52-Week low 0.1
52-Week high 0.24
Beta 0.51
50-Day moving average 0.13
200-Day moving average 0.17
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.72%
Operating margin -1.6%
Operational effectiveness
Return on assets -0.23%
Return on equity -3.01%
Income Statement
Revenue (ttm) 57.46M
Revenue per share (ttm) 0.86
Quarterly revenue growth (yoy) 8.03%
Gross profit (ttm) -
EBITDA -4.57M
Net income to common (ttm) -110.01M
Diluted EPS (ttm) -0.08
Quarterly earnings growth (yoy) 8.8%
Balance Sheet
Total cash (mrq) 6K
Total cash per share (mrq) 0
Total debt (mrq) 27.08M
Total Debt/Equity (mrq) 67.98
Current ratio (mrq) 0.88%
Book value per share (mrq) 0.49
Cash Flow
Cash flow statement -51.66M
Levered free cash flow (LFCF) -7.01M
